Wednesday, 20 August 2003: 15:45-17:15
Superior Room (Sheraton Hotel and Towers)

S073 Health Economics and Public Health Implications of Alzheimer's Disease with and without Medical Co-Morbidities

Although it is well known that the societal costs of Alzheimer´s disease and related dementias (ADRD) are extremely high, it is also obvious that there is a complex interaction between ADRD and comorbid conditions. This fact may be one explanation to the great range in cost of illness studies of dementia. Comorbidity may also act as a confounder in intervention studies (pharmacological as well as non-pharmacological) of ADRD. The effects of comorbidity on the course of ADRD in terms of resource utililization and costs are not sufficiently known and there is a great need for deeper studies in this field. This symposium will present health economical results from Sweden, the USA and Canada where different aspects of ADRD and comorbidity are highlighted.
Chair:Anders Wimo
 S073-001 Comorbidity and Costs of Dementia
Anders Wimo, Inga Klarin, Britt-Marie Sjolund, Eva I Von Strauss
 S073-002 The Societal Costs of Incident Vascular Cognitive Impairment (VCI) and Alzheimer's Disease in the Canadian Study of Health and Aging
Kenneth Rockwood, Chris Skedgel, John D Fisk
 S073-003 Factors Associated with AD Disease Progression (Including Comorbidities) to Nursing Home Placement and Mortality
Joel Hay, Danielle Zammit
 S073-004 Cost of Care and Quality of Life in Patients with Alzheimer's Disease in Relation to Comorbidities: Results from a Nordic Study
Linus Jönsson, Maria Eriksdotter-Jönhagen, Lena Kilander, Hilkka Soininen, Gunhild Waldemar, Harald Nygaard
 S073-005 Alzheimer's Disease and Related Dementias and Costs of Comorbidities in Managed Medicare
Jerrold Hill, Howard Fillit, Robert Futterman, Vera Mastey

Back to The Eleventh International Congress